Professional Documents
Culture Documents
Cardioembolism
- Anticoagulation
Undetermined
Ticlopidine
Clopidogrel
Cilostazol *
Triflusal
(Ticagrelor, Prasugrel)
Primary endpoints
Secondary endpoints
Future study verifying patients who may benefit from Cilostazol may
be needed.
Cardioembolic Stroke
Warfarin & 4 Commercially Available NOACs
When to start?
Paroxysmal Af
Others
Role of NOAC?
Ongoing NOAC Trial for ESUS
RE-SPECT ESUS (Dabigatran)
Randomized Evaluation in Secondary stroke PrEvention Comparing the Thrombin
inhibitor dabigatran etexilate versus acetylsalicylic acid (ASA) in Embolic Stroke of
Undetermined Source
ATTICUS (Apixaban)
Apixaban for Treatment of Embolic Stroke of Undetermined Source
Summary - Antithrombotic Therapy
DAPT for Stroke Prevention
Negative for Long Term Prevention & Small Vessel Disease
Positive only for Short Term (<3 weeks), ICAS
Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. The New England journal of
medicine. 2013;369:11-19
Liu L, Wong KS, Leng X, Pu Y, Wang Y, Jing J, et al. Dual antiplatelet therapy in stroke and icas: Subgroup analysis of chance. Neurology. 2015;85:1154-1162
Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic
stroke: A systematic review and meta-analysis. Annals of internal medicine. 2013;159:463-470
Wong KSL, Wang Y, Leng X, Mao C, Tang J, Bath PMW, et al. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient
ischemic attack: An updated systematic review and meta-analysis. Circulation. 2013;128:1656-1666
Investigators SPS, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, et al. Effects of clopidogrel added to aspirin in patients with recent lacunar
stroke. The New England journal of medicine. 2012;367:817-825
Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to
ageing and neurodegeneration. The Lancet Neurology. 2013;12:822-838
Kim JT, Park MS, Choi KH, Cho KH, Kim BJ, Han MK, et al. Different antiplatelet strategies in patients with new ischemic stroke while taking aspirin. Stroke; a journal
of cerebral circulation. 2016;47:128-134
Ottosen TP, Grijota M, Hansen ML, Brandes A, Damgaard D, Husted SE, et al. Use of antithrombotic therapy and long-term clinical outcome among patients
surviving intracerebral hemorrhage. Stroke; a journal of cerebral circulation. 2016;47:1837-1843
Hong KS, Kim BJ, Kwon SU, Investigators P. Rationale and design of the prevention of cardiovascular events in ischemic stroke patients with high risk of cerebral
hemorrhage (picasso) study: A randomized controlled trial. International journal of stroke. 2015;10:1153-1158
Diener HC, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J, et al. Choosing a particular oral anticoagulant and dose for stroke prevention in individual
patients with non-valvular atrial fibrillation: Part 2. European heart journal. 2016
Diener HC, Aisenberg J, Ansell J, Atar D, Breithardt G, Eikelboom J, et al. Choosing a particular oral anticoagulant and dose for stroke prevention in individual
patients with non-valvular atrial fibrillation: Part 1. European heart journal. 2016
Heidbuchel H, Hacke W, et al. Updated european heart rhythm association practical guide on the use of non-vitamin-k antagonist anticoagulants in patients with
non-valvular atrial fibrillation: Executive summary. European heart journal. 2016
Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee TH, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. The New
England journal of medicine. 2016